Cargando…

Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients

BACKGROUND: Opioid receptors have become increasingly implicated in cancer progression and long-term patient outcomes. However, the expression and significance of the κ-opioid receptor (KOR) in hepatocellular carcinoma (HCC) remain unclear. METHODS: In this study, KOR mRNA expression was analysed by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dongtai, Chen, Yonghua, Yan, Yan, Pan, Jiahao, Xing, Wei, Li, Qiang, Zeng, Weian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562986/ https://www.ncbi.nlm.nih.gov/pubmed/28821282 http://dx.doi.org/10.1186/s12885-017-3541-9

Ejemplares similares

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth
por: Yan, Yan, et al.
Publicado: (2022)

Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Yan, Yan, et al.
Publicado: (2022)

Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin via upregulation of RASSF1A expression and demethylation
por: Chen, Dongtai, et al.
Publicado: (2020)

Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma
por: Yan, Yan, et al.
Publicado: (2020)

Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma
por: Qi, Zhenhua, et al.
Publicado: (2020)

The nociceptin receptor promotes autophagy through NF-kB signaling and is transcriptionally regulated by E2F1 in HCC
por: Zhou, Xiaoshuang, et al.
Publicado: (2022)

Intraoperative low-dose dopamine is associated with worse survival in patients with hepatocellular carcinoma: A propensity score matching analysis
por: Wang, Yan, et al.
Publicado: (2022)

Dexmedetomidine Alleviates Hypoxia-Induced Synaptic Loss and Cognitive Impairment via Inhibition of Microglial NOX2 Activation in the Hippocampus of Neonatal Rats
por: Chen, Xiaohui, et al.
Publicado: (2021)

Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma
por: Sun, Wu-Yi, et al.
Publicado: (2016)

The Relationship between Blood Lead Level and Chronic Pain in US Adults: A Nationwide Cross-Sectional Study
por: Wang, Wanyu, et al.
Publicado: (2023)

Potential influence of anaesthesia techniques on the recurrence and progression after resection of non-muscle-invasive bladder cancer: a propensity score-matched analysis
por: Xue, Ruifeng, et al.
Publicado: (2022)

Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma
por: Sheng, Xu-Ren, et al.
Publicado: (2018)

Down‐regulation of TROP‐2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients
por: Sin, Sarah T. K., et al.
Publicado: (2018)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma
por: Aigelsreiter, A, et al.
Publicado: (2013)

Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma
por: Li, Aimin, et al.
Publicado: (2015)

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
por: Chen, Xiaohui, et al.
Publicado: (2022)

Down‐regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients
por: Wang, Ling, et al.
Publicado: (2018)

PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Hao, et al.
Publicado: (2019)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

MBD3 promotes hepatocellular carcinoma progression and metastasis through negative regulation of tumour suppressor TFPI2
por: Yan, Weiwei, et al.
Publicado: (2022)

Impact of preoperative anemia on relapse and survival in breast cancer patients
por: Zhang, YingJun, et al.
Publicado: (2014)

Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
por: Yang, Guoliang, et al.
Publicado: (2017)

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer
por: Sun, Ruochuan, et al.
Publicado: (2014)

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
por: Yan, Xiaotong, et al.
Publicado: (2019)

Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma
por: Huang, He-Qing, et al.
Publicado: (2021)

FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2020)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration
por: Wang, Jieyan, et al.
Publicado: (2023)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma
por: Zou, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q189ojnue0tj08gc89bm6vh0ra